Providing oncologists with in-depth analysis to guide decisions about personalized cancer therapy based on comprehensive genomic profiling.

HLI Cancer Exome Test

This test analyzes a patient’s normal DNA and tumor DNA, along with tumor RNA, to provide detailed information on the molecular profile of their cancer. The results can reveal reasons for failed treatments and options for improved personalized therapies.

HLI can:

  • Identify targeted cancer treatments
  • Determine if any new cancer treatments might be effective
  • Identify if a patient may benefit from immunotherapeutics
  • Determine if a patient has an inherited cancer risk

HLI Inherited Cancer Risk Test

For family members who want to understand if they may be predisposed to a higher risk of developing cancer.

Find out more

To get more information, please provide: